by adminTorusBrand | May 3, 2017 | Axim Biotechnologies, Press Releases
SAN DIEGO, May 3, 2017 — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc.’s (AXIM® Biotech) (AXIM) product development...
by adminTorusBrand | Apr 19, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway
The cannabis community had much to celebrate this year. From the expansion of marijuana access to an increase in cannabis research, this amazing plant and the incredible industry that has sprung up around it has experienced unprecedented growth since last 4/20. There...
by adminTorusBrand | Mar 30, 2017 | Axim Biotechnologies, Company News, Scientific Research
[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies, a major Medical Marijuana, Inc. investment company, has taken the first steps toward developing a chewing gum bioequivalent to Marinol, made using a synthetic version of THC or tetrahydrocannabinol. This week,...
by adminTorusBrand | Mar 28, 2017 | Axim Biotechnologies, Press Releases
[vc_row][vc_column][vc_column_text]SAN DIEGO, March 28, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech)...
by adminTorusBrand | Mar 23, 2017 | Axim Biotechnologies, Press Releases, Scientific Research
In order to fast-track approval of its new products, AXIM® Biotechnologies, Inc., a Medical Marijuana, Inc. investment company, has retained the services of Ora®, Inc. for the development of its cannabinoid-based eye treatments. A global Contract Research...
